Promote Sponsor
verified SJR 0,168 · Q4 • database Scopus / SJR indexed
Current Enzyme Inhibition
United Arab Emirates · Bentham Science Publishers
workspace_premium Q4 — Biochemistry lock Subscription Unclaimed

Current Enzyme Inhibition

Current Enzyme Inhibition is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 19. It has an SJR impact factor of 0,168 and it has a best quartile of Q4. It has an SJR impact factor of 0,168.

ISSN: 1573-4080
Editorial: Bentham Science Publishers
Category: Biochemistry
Indexation: verifiedScopus / SJR

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,168 Q4
H-index 19
Tasa de Aceptación pie_chart
42%
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR

SJR Impact

0,168

H-index

19

Docs (year)

20

Docs 3y

72

Total refs

1335

Cites 3y

46

Citable 3y

67

Cites/Doc 2y

0.66

Ref/Doc

66.75

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiac and Renal Nitric Oxide in the Adaptation to Hypovolemic Shock

View more

Vascular Endothelial Growth Factor (VEGF) in Pleural Effusions

View more

Defense Against Oxidative Tissue Injury: The Essential Role Played by Heme Oxygenase-1

View more

Cytoprotective and Antiproliferative Effects of HMG-CoA Reductase Inhibitors

View more

CYP Inhibition-Mediated Drug-Drug Interactions

View more

Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter

View more

Competitive Parabolic Inhibition of Rat Tissue Kallikrein by Aprotinin

View more

CoMFA, CoMSIA and Docking Studies of Saquinavir Based Peptidomimetic Inhibitors of HIV-1 Protease

View more

Colorectal Carcinogensis and Suppression of Tumor Development by Inhibition of Enzymes and Molecular Targets

View more

Clostridium difficile DNA Polymerase IIIC: Basis for Activity of Anti-Bacterial Compounds

View more

Cholinesterases and Cholinesterase Inhibitors

View more

Cholinesterase Inhibitors: From Weapons, to Pesticides, to Cognition Enhancing Drugs

View more
SHOW MORE ARTICLES

Celecoxib Modulates the Renin-Angiotensin System in the Adipose Tissue of Obese Mice

View more

alpha-Amylase Inhibition: Some Practical Considerations

View more

Carbonic Anhydrase I and II Inhibition with Natural Products: Abrus precatorius

View more

Caenorhabditis elegans: Study Model for Animal and Human Cathepsins and Inhibitors

View more

Breast Cancer Chemoprevention: Current Perspectives

View more

Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance

View more

Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy

View more

Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors

View more

Anti-inflammatory Activities of Phenoxyphenyl Ureas Mediated by Inhibition of p38 Kinase

View more

Anti-Acetylcholinesterase Derivatives: A Privileged Structural Framework in Drug Discovery to Treat Alzheimer's Disease

View more

Angiotensin-Converting Enzyme - New Insights into Structure, Biological Significance and Prospects for Domain-Selective Inhibitors

View more

Acknowledgements to Reviewers:

View more

FAQS